{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:18:57Z","timestamp":1792592337625,"version":"4.5.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>This review summarizes recent advances in applying metabolomics to autoimmune hepatitis (AIH). AIH is a chronic liver disease characterized by immune-mediated hepatocellular injury, with complex pathogenesis involving genetic, immunological, and environmental factors. Metabolomics, a system-wide approach analyzing small molecule metabolites, offers potential in early diagnosis, prognosis, and therapeutic evaluation of AIH. Current studies identify alterations in amino acid, lipid, carbohydrate, and bile acid metabolism, as well as changes in the gut microbiome and specific metabolite markers that distinguish AIH from other liver diseases. Techniques such as liquid chromatography-mass spectrometry (LC\u2013MS), and bioinformatics facilitate biomarker discovery and enhance understanding of disease mechanisms. Despite challenges such as standardization and data integration, metabolomics holds promise for developing personalized treatment strategies and advancing disease management. Future prospects include combining multi-omics approaches, large-scale cohort studies, and artificial intelligence (AI)-based data analysis to deepen insights into AIH pathology and improve clinical outcomes.<\/jats:p>","DOI":"10.3389\/fmed.2025.1667391","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:10:29Z","timestamp":1762236629000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Metabolomics in autoimmune hepatitis: progress and perspectives"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaotong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0168-8278(02)00408-7","article-title":"Waldenstr\u00f6m J. Leber. Blutproteine und Nahrungseiweiss [Deutsch Z Verdau Stoffwechselkr 1950;15:113\u2013119]","volume":"38","author":"zum B\u00fcschenfelde","year":"2003","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/MCG.0000000000001449","article-title":"Epidemiology of autoimmune hepatitis (AIH) in the United States between 2014 and 2019: a population-based national study","volume":"55","author":"Tunio","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102280","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis","volume":"65","author":"Hahn","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000455177","article-title":"Autoimmune hepatitis in the east and the west","volume":"1","author":"Ngu","year":"2017","journal-title":"Inflammatory Intestinal Diseases"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"947382","DOI":"10.3389\/fcimb.2022.947382","article-title":"The gut microbiota: a novel player in autoimmune hepatitis","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaut.2018.10.004","article-title":"The clinical usage and definition of autoantibodies in immune-mediated liver disease: a comprehensive overview","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J Autoimmun"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","article-title":"Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?","volume":"42","author":"Gatselis","year":"2010","journal-title":"Dig Liver Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.51821\/84.3.014","article-title":"Diagnostic and prognostic scoring systems for autoimmune hepatitis: a review","volume":"84","author":"Ducazu","year":"2021","journal-title":"Acta Gastroenterol Belg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"103162","DOI":"10.1016\/j.jaut.2023.103162","article-title":"Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis","volume":"143","author":"Gao","year":"2024","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"102619","DOI":"10.1016\/j.jaut.2021.102619","article-title":"Regulatory T cells in autoimmune hepatitis: an updated overview","volume":"119","author":"Longhi","year":"2021","journal-title":"J Autoimmun"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.chom.2022.05.006","article-title":"Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis","volume":"30","author":"Pandey","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/HEP.0000000000000767","article-title":"NMR-based metabolomic signature: an important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis","volume":"80","author":"Dimou","year":"2024","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1073\/pnas.0909737107","article-title":"Homocystamides promote free-radical and oxidative damage to proteins","volume":"107","author":"Sibrian-Vazquez","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/microorganisms8071011","article-title":"Autoimmune hepatitis: shifts in gut microbiota and metabolic pathways among Egyptian patients","volume":"8","author":"Elsherbiny","year":"2020","journal-title":"Microorganisms"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1021\/pr500462f","article-title":"Metabolomic profiling of autoimmune hepatitis: the diagnostic utility of nuclear magnetic resonance spectroscopy","volume":"13","author":"Wang","year":"2014","journal-title":"J Proteome Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"9171905","DOI":"10.1155\/2018\/9171905","article-title":"Functions and signaling pathways of amino acids in intestinal inflammation","volume":"2018","author":"He","year":"2018","journal-title":"Biomed Res Int"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1007\/s00018-021-03828-4","article-title":"Arginine-dependent immune responses","volume":"78","author":"Mart\u00ed","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00726-021-03051-2","article-title":"Proline metabolism and redox; maintaining a balance in health and disease","volume":"53","author":"Vettore","year":"2021","journal-title":"Amino Acids"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e0171722","DOI":"10.1128\/spectrum.01717-22","article-title":"Multi-omics analysis reveals the protection of Gasdermin D in Concanavalin A-induced autoimmune hepatitis","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"880262","DOI":"10.3389\/fimmu.2022.880262","article-title":"Targeting glutamine metabolism ameliorates autoimmune hepatitis via inhibiting T cell activation and differentiation","volume":"13","author":"Yu","year":"2022","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"982186","DOI":"10.3389\/fimmu.2022.982186","article-title":"Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"644376","DOI":"10.3389\/fmed.2021.644376","article-title":"Metabolomic signatures of autoimmune hepatitis in the development of cirrhosis","volume":"8","author":"Li","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1039\/C6MB00092D","article-title":"Metabolism of glycerophospholipid, bile acid and retinol is correlated with the early outcomes of autoimmune hepatitis","volume":"12","author":"Zhou","year":"2016","journal-title":"Mol BioSyst"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"Oc17","DOI":"10.7860\/JCDR\/2017\/24958.9621","article-title":"The importance of liver-fatty acid binding protein in diagnosis of liver damage in patients with acute hepatitis","volume":"11","author":"Cakir","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1041885","DOI":"10.3389\/fmicb.2022.1041885","article-title":"Impacts of sodium butyrate on intestinal mucosal barrier and intestinal microbial community in a weaned piglet model","volume":"13","author":"Liu","year":"2022","journal-title":"Front Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms21176356","article-title":"Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"726128","DOI":"10.3389\/fphar.2021.726128","article-title":"Glucose metabolism reprogramming of regulatory T cells in Concanavalin A-induced hepatitis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.2147\/IJN.S472086","article-title":"Metabolic reprogramming of CD4(+) T cells by mesenchymal stem cell-derived extracellular vesicles attenuates autoimmune hepatitis through mitochondrial protein transfer","volume":"19","author":"Shen","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1179\/1351000214Y.0000000101","article-title":"Oxidative stress and antioxidant status in patients with autoimmune liver diseases","volume":"20","author":"Kaffe","year":"2015","journal-title":"Redox Rep"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12967-024-05173-z","article-title":"Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases","volume":"22","author":"Pongracz","year":"2024","journal-title":"J Transl Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"Wishart","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-0239-3_1","article-title":"Overview of experimental methods and study design in metabolomics, and statistical and pathway considerations","volume":"2104","author":"Barnes","year":"2020","journal-title":"Methods Mol Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/2213235X11301010092","article-title":"Multivariate analysis in metabolomics","volume":"1","author":"Worley","year":"2013","journal-title":"Curr Metabolomics"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1499-3872(15)60393-9","article-title":"A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis","volume":"14","author":"Lian","year":"2015","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.3748\/wjg.v28.i39.5764","article-title":"Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis","volume":"28","author":"Ma","year":"2022","journal-title":"World J Gastroenterol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-024-05029-6","article-title":"Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome","volume":"22","author":"Yang","year":"2024","journal-title":"J Transl Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jceh.2017.01.115","article-title":"Role of allopurinol in optimizing thiopurine therapy in patients with autoimmune hepatitis: a review","volume":"7","author":"Deswal","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"11233","DOI":"10.3390\/ijms252011233","article-title":"Analysis of azathioprine metabolites in autoimmune hepatitis patient blood-method development and validation","volume":"25","author":"Guba","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"111838","DOI":"10.1016\/j.jep.2019.111838","article-title":"Metabolomics profiling in a mouse model reveals protective effect of Sancao granule on con A-induced liver injury","volume":"238","author":"Yang","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J Autoimmun"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.20524\/aog.2024.0924","article-title":"Hellenic association for the study of the liver (HASL): revised clinical practice guidelines for autoimmune hepatitis","volume":"37","author":"Dalekos","year":"2024","journal-title":"Ann Gastroenterol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1667391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:10:30Z","timestamp":1762236630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1667391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":49,"alternative-id":["10.3389\/fmed.2025.1667391"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1667391","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"1667391"}}